Systemic lupus erythematosus: Mortality and survival in Argentina. A multicenter study

Lupus

Volumn 9, Issue 5, 2000, Pages 377-381

  Bellomio, V ⁱ   Spindler, A ⁱ   Lucero, E ⁱ   Berman, A ⁱ   Santana, M ⁱ   Moreno, C ⁱ   Pardo Hidalgo, R ⁱ   Paira, S ^a   Graf, C ^a   Maldonado Cocco, J A ^b   Citera, G ^b   Arriola, M S ^b   Gomez G ^b   Barreira, J C ^c   Messina, O ^c   Asnal, C ^c   Carrillo, D ^d   Gervilla, A ^d   Garcia L ^d   Mascolo M ^d   De La Sota, M ⁱ   Rosso, G ^e   Somma, L F ^f   Fernandez Sosa R ^g   Rillo, O ^h   Caracciolo, J A ^h   Lancioni, G ^h   Gomez A ^h   more..

^a Hospital Jose M Cullen   (Argentina)

^b IMUREP   (Argentina)

^c HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

^d Hospital Pablo Soria   (Argentina)

^e Hospital Gral de Agudos   (Argentina)

^f GEMA Group DCB   (Argentina)

^g Hospital Dr Ramon Madariaga   (Argentina)

^h Tornu Hospital   (Argentina)

ⁱ NONE

Author keywords

Mortality; Survival; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARGENTINA; ARTICLE; CAUSE OF DEATH; DISEASE DURATION; FEMALE; HEART DISEASE; HUMAN; HYPERLIPIDEMIA; INFECTION; KIDNEY DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOSITIS; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEPSIS; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ARGENTINA; CHILD; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 0034046233     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gladman D. Prognosis of systemic lupus erythematosus and factors that affect it. Curr Opin Rheumatol 1992; 4: 681-687.
2. Gladman D. Indicators of disease activity, prognosis, and treatment of systemic lupus erythematosus. Curr Opin Rheumatol 1993; 5: 587-595.
3. Ward MM, Pyun E, Studensky S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 1995; 38: 274-283.
4. Urowitz M, Gladman D, Abu-Shakra M, Farewel V. Mortality studies in systemic lupus erythematosus. Results from a single center II. Improved survival over 24 years. J Rheumatol 1997; 24: 1061-1065.
5. Blanco FJ, Gomez-Reino J, de la Mata J et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 1998; 7: 159-163.
6. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center II. Predictor variables for mortality. J Rheumatol 1995; 22: 1265-1270.
7. Reveille JD, Bartolucci A, Alarcón GS. Prognosis in systemic lupus erythematosus: negative impact of increasing age at onset, black race and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990; 33: 37-48.
8. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J Mortality studies in systemic lupus erythematosus. Results from a single center I. Causes of death. J Rheumatol 1995; 22: 1259-1264.
9. Duffy KN, Duffy CM, Gladman DD. Infection and disease activity in SLE: a review of hospitalized patients. J Rheumatol 1991; 18: 1180-1184.
10. Cervera R, Font J, Sebastiani GD et al. 'Euro-Lupus' Project: 5-year prospective study of morbidity and mortality in a cohort of 1000 patients with SLE. Arthritis Rheum 1997; 40: S161 (Abstract).
11. Massardo L, Martinez ME, Jacobelli S et al. Survival of Chilean patients with systemic lupus erythematosus. Semin Arthritis Rheum 1994; 24: 1-11.
12. Studensky S, Allen N, Caldwell D, Rice J, Polison R. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum 1987; 30: 1326-1332.
13. Ward MM, Pyun E, Studensky S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med 1996; 56: 1337-1344.
14. Spindler A, Berman A, Lucero E et al. Mortalidad en Lupus Eritematoso Sistémico. Análisis de Sobrevida. Rev Arg Rheumatol 1998; 9: 58-63.
15. Alarcón GS. Epidemiology of rheumatic diseases in Latin America. Bol Sanit Panam 1986; 101: 309-326.
16. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Slat Assoc 1953; 53: 457-481.
18. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-202.
19. Fernandez RN. LES: experiencia de 5 años. Rev Brasil Rheumatol 1992; 32: 41 (Suppl).
20. Ward MM, Pyun E, Studensky S. Causes of death in systemic lupus erythematosus. Long-term follow-up of an inception cohort. Arthritis Rheum 1995; 38: 1492-1499.
21. Petri M. Male lupus differs from female lupus in presentation and outcome. Arthritis Rheum 1997; 40: S162 (abstract).
22. Wallace DJ. Prognostic subsets and mortality in systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds.) Dubois Lupus Erythematosus. Lea & Febiger: Baltimore, Maryland, 1993, pp. 606-615.
23. Seleznick MJ, Fries JF. Variables associated with decreased survival in systemic lupus erythematosus. Semin Arthritis Rheum 1991; 21: 73-80.
24. Reveille JD, Alarcón GS. Survival in systemic lupus erythematosus: demographic, socioeconomic, clinical factors, and causes of death. Arthritis Rheum 1986; 29(Suppl): S27.
25. Catoggio LJ, Skinner PP, Smith G. Systmeic Lupus Erythematosus in the elderly: clinical and serological characteristics. J Rheumatol 1984; 11: 175-181.
26. Wilson HA, Hamilton ME, Spyker DA. Age influences in clinical and serological expression of Systemic Lupus Erythematosus. Arthritis Rheum 1981; 24: 1230-1235.
27. Urowitz MB, Brookman AAN, Koehler BE et al. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976; 60: 221-225.
28. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med 1985; 55: 87-98.